A Dark Vector Cognition product

Item 16. FORM 10-K SUMMARY

5K characters. Original on sec.gov ·

Item 16. FORM 10-K SUMMARY

Not applicable.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Pleasanton, State of California, on this 27th day of February, 2023.

WORKDAY, INC.
/s/ Barbara Larson
Barbara Larson Chief Financial Officer (Principal Financial and Accounting Officer)

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Barbara Larson or Richard H. Sauer, or any of them, his or her attorneys-in-fact, for such person in any and all capacities, to sign any amendments to this report and to file the same, with exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that either of said attorneys-in-fact, or substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Table of Contents

SignatureTitleDate
/s/ Aneel BhusriCo-Chief Executive OfficerFebruary 27, 2023
Aneel Bhusri(Principal Executive Officer)
/s/ Carl M. EschenbachCo-Chief Executive OfficerFebruary 27, 2023
Carl M. Eschenbach(Principal Executive Officer)
/s/ Barbara LarsonChief Financial OfficerFebruary 27, 2023
Barbara Larson(Principal Financial and Accounting Officer)
/s/ Thomas F. BoganDirectorFebruary 27, 2023
Thomas F. Bogan
/s/ Ann-Marie CampbellDirectorFebruary 27, 2023
Ann-Marie Campbell
/s/ Christa DaviesDirectorFebruary 27, 2023
Christa Davies
/s/ Lynne M. DoughtieDirectorFebruary 27, 2023
Lynne M. Doughtie
/s/ Wayne A.I. Frederick, M.D.DirectorFebruary 27, 2023
Wayne A.I. Frederick, M.D.
Director
Mark J. Hawkins
/s/ Michael M. McNamaraDirectorFebruary 27, 2023
Michael M. McNamara
/s/ George J. Still, Jr.DirectorFebruary 27, 2023
George J. Still, Jr.
/s/ Lee J. Styslinger IIIDirectorFebruary 27, 2023
Lee J. Styslinger III
/s/ Jerry YangDirectorFebruary 27, 2023
Jerry Yang

Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES